Gliomas, being the most commonly occurring primary malignant brain tumors in adults (1), are classified by the 2021 version of the World Health Organization (WHO) into three groups based on two critical molecular markers: the isocitrate dehydrogenase (IDH) genotype and 1p/19q codeletion status. Here, IDH1 is linked to central nervous system cancer.